Clinical trial
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal…
NCT00165425 · Dana-Farber Cancer Institute, Other · Active, not recruiting
Key facts
| NCT number | NCT00165425 |
|---|---|
| Title | Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation |
| Official title | Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Hodgkin's Disease |
| Intervention type | Procedure |
| Interventions | Echo/Stress Echo |
| Enrollment | 210 |
| Start date | Feb 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2028 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 10, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: